Kerstin Pfister, Thomas W. P. Friedl, Andreas Hartkopf, Franziska Mergel, Sophia Huesmann, Forca Mehmeti, Henning Schäffler, Angelina Fink, Tatjana Braun, Sabine Heublein, Lisa Wiesmüller, Klaus Pantel, Brigitte Rack, Peter A. Fasching, Wolfgang Janni. "Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy." PLoS ONE, 2025. doi:10.1371/journal.pone.0322156